Landec Corp (LNDC) 12.12 $LNDC
Landec Corporation Reports Third Quarter and First Nine Months of Fiscal 2014 Results
GlobeNewswire - Tue Mar 25, 3:30PM CDT
Landec Corporation (Nasdaq:LNDC), a materials science Company that develops and markets innovative and patented products for healthy living applications in food and biomedical markets, reported results for the fiscal 2014 third quarter and nine months ended February 23, 2014.
Landec Has Returned 22.4% Since SmarTrend Recommendation (LNDC)
Comtex SmarTrend(R) - Thu Mar 06, 9:55AM CST
SmarTrend identified a Downtrend for Landec (NASDAQ:LNDC) on August 12th, 2013 at $14.05. In approximately 7 months, Landec has returned 22.39% as of today's recent price of $10.90.
Landec Corporation Sets Third Quarter 2014 Conference Call for March 26, 2014 at 8 a.m. PT; Earnings Release Set for March 25, 2014 After Market
GlobeNewswire - Tue Mar 04, 3:07PM CST
Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday, March 26, 2014 at 8 a.m. Pacific time to discuss its results for the third quarter 2014. Financial results will be reported for the fiscal year 2014 third quarter ended February 23, 2014 after market close on March 25, 2014.
Landec to Present at the 26th Annual ROTH Conference on March 12, 2014
GlobeNewswire - Thu Feb 27, 12:00PM CST
Landec Corporation (Nasdaq:LNDC), a materials science company that develops and markets innovative and patented products for healthy living applications in food and biomedical markets, has been invited to present at the 26th Annual ROTH Conference being held March 10 - 12, 2014 at the Ritz Carlton in Dana Point, California.
Opus Group announces signing of vehicle inspection contract in Colorado
M2 - Wed Feb 26, 5:02AM CST
Opus Group AB (STO:OPUS.ST) announced today that Envirotest Systems Corp (Envirotest) has signed an exclusive contract with the Colorado Department of Public Health and Environment to continue operating the centralised vehicle inspection program for the state of Colorado.
Commercial Applications Expanding for Landec BreatheWay Produce Packaging
GlobeNewswire - Tue Feb 25, 9:25AM CST
Landec Corporation (Nasdaq:LNDC), a materials science company that develops and markets innovative and patented products for healthy living applications in food and biomedical markets, is expanding commercial applications for its patented BreatheWay(R) technology packaging solutions. Landec's BreatheWay technology naturally extends the shelf-life of fresh fruits and vegetables by optimizing the ratio of carbon dioxide and oxygen within the packaging. Expanding commercial applications using BreatheWay technology include:
Landec Shares Down 28.1% Since SmarTrend's Sell Call (LNDC)
Comtex SmarTrend(R) - Wed Feb 19, 4:59PM CST
SmarTrend identified a Downtrend for Landec (NASDAQ:LNDC) on August 12th, 2013 at $14.05. In approximately 6 months, Landec has returned 28.09% as of today's recent price of $10.10.
Global Biomaterials Market 2012-2016: High R&D Costs Could Pose a Challenge to the Growth of the Market
M2 - Wed Feb 05, 10:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/kl58bq/global) has announced the addition of the "Global Biomaterials Market 2012-2016" report to their offering. The analysts forecast the Global Biomaterials market to grow at a CAGR of 14.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Biomaterials market has also been witnessing the emergence of innovative biomaterial products. However, high R&D costs could pose a challenge to the growth of this market. The key vendors dominating this space include Biomet Inc., Evonik Industries AG, Exactech Inc., and Wright Medical Group Inc. The other vendors mentioned in this report are 3DM Inc., AdvanSource Biomaterials Corp., Allergan Inc., Alphatec Spine Inc., Amedica Corp., Angiotech Pharmaceuticals Inc., Basf SE, Bayer AG, Berkeley Advanced Biomaterials Inc., Biocomposites Ltd., BioSyntech Inc., Cam Bioceramics BV, Carpenter Technology Corp., Ceradyne Inc., Ceramtec Collagen Matrix Inc., CollPlant Holdings Ltd., Covalon Technologies Ltd., CryoLife Inc., Dentsply International Inc., Depuy Orthopaedics Inc., Dsm Biomedical Inc., ETEX Corp., Heraeus Medical Components Inc., Hycail Finland OY, Integra LifeSciences Holdings Corp., Invibio Ltd., Kyocera Corp., Landec Corp., Materion Corp., Medtronic Inc., Morgan Technical Ceramics, Orthovita Inc., Osteotech Inc., Purac Biomaterials, RTI Biologics Inc., Sigma-Aldrich Corp., Starch Medical Inc., Stryker Corp., Ticona GmbH, Ulbrich Stainless Steels & Special Metals Inc., and Zimmer Holdings Inc. Commenting on the report, an analyst from the team said: There has been steady innovation in the Global Biomaterials market with several players increasing R&D expenditure every year. For instance, the use of carbon fiber in conjunction with biomaterials for the manufacture of composite materials is being explored. While innovation is imperative in an industry such as this where competition is rampant, the need for novel solutions to cater to patient needs in the Medical industry is also expected to lead to innovation in the market. Biomaterials were traditionally used for repair and replacement of body tissues. However, there has been an increasing focus on the provision of biomaterials for self-healing in patients. Thus, the Global Biomaterials market is expected to witness innovation. For more information visit http://www.researchandmarkets.com/research/kl58bq/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Landec Down 28.2% Since SmarTrend Downtrend Call (LNDC)
Comtex SmarTrend(R) - Wed Feb 05, 9:46AM CST
SmarTrend identified a Downtrend for Landec (NASDAQ:LNDC) on August 12th, 2013 at $14.05. In approximately 6 months, Landec has returned 28.16% as of today's recent price of $10.09.
Landec Shares Down 19.8% Since SmarTrend's Sell Call (LNDC)
Comtex SmarTrend(R) - Tue Jan 21, 5:28PM CST
SmarTrend identified a Downtrend for Landec (NASDAQ:LNDC) on August 12th, 2013 at $14.05. In approximately 5 months, Landec has returned 19.76% as of today's recent price of $11.27.
Landec Down 19.3% Since SmarTrend Downtrend Call (LNDC)
Comtex SmarTrend(R) - Mon Jan 13, 9:34AM CST
SmarTrend identified a Downtrend for Landec (NASDAQ:LNDC) on August 12th, 2013 at $14.05. In approximately 5 months, Landec has returned 19.33% as of today's recent price of $11.33.
Post Earnings Update: Landec Has Sunk 5.1% Lower in Past Week (LNDC)
Comtex SmarTrend(R) - Mon Jan 13, 6:59AM CST
A week ago on January 2nd, 2014 Landec (NASDAQ:LNDC) reported earnings and analysts, on average, expected earnings of $0.13 on sales of $124.0 million. Landec actually reported earnings of $0.13 per share on sales of $120.0 million, matching EPS estimates and missing revenue estimates by $4.0 million. Since the company's report, shares of Landec have fallen from $12.02 to $11.41, representing a loss of 5.1% in the past 11 days.
Landec Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 09, 11:00AM CST
On Jan 8, Zacks Investment Research downgraded materials sciences company Landec Corporation to a Zacks Rank #5 (Strong Sell).
Landec Appoints Molly Hemmeter as COO - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 11:10AM CST
Landec Corporation, a materials sciences company, has announced the appointment of Molly A. Hemmeter as its Chief Operating Officer (COO).
Landec Corporation hires Molly Hemmeter as COO
M2 - Mon Jan 06, 7:54AM CST
Materials science company Landec Corporation (NasdaqGS:LNDC) revealed on Friday the election of Molly A. Hemmeter as its chief operating officer, reporting directly to its CEO and board chair, Gary Steele.
Landec Corporation Announces Appointment of Molly Hemmeter as Chief Operating Officer
GlobeNewswire - Fri Jan 03, 8:15AM CST
Landec Corporation (Nasdaq:LNDC) a developer and marketer of technology-based materials science products for food and medical applications today announced the appointment of Molly A. Hemmeter as Landec's Chief Operating Officer. Ms. Hemmeter joined Landec in June 2009 as VP of Business Development and subsequently became Landec's Chief Commercial Officer. Ms. Hemmeter will report directly to Gary Steele, Landec's CEO and Chairman of the Board.
LANDEC CORP.
at Investor's Business Daily - Thu Jan 02, 5:49PM CST
LANDEC CORP. (LNDC), a materials maker for the food and health care industries, said Q2 EPS fell 61% to 13 cents, in line with views. Revenue rose 5% to $120 mil, under. Shares fell 3.1%.
Landec Corporation Reports Third Quarter and First Nine Months of Fiscal 2014 Results
GlobeNewswire - Tue Mar 25, 3:30PM CDT
Landec Corporation (Nasdaq:LNDC), a materials science Company that develops and markets innovative and patented products for healthy living applications in food and biomedical markets, reported results for the fiscal 2014 third quarter and nine months ended February 23, 2014.
Landec Has Returned 22.4% Since SmarTrend Recommendation (LNDC)
Comtex SmarTrend(R) - Thu Mar 06, 9:55AM CST
SmarTrend identified a Downtrend for Landec (NASDAQ:LNDC) on August 12th, 2013 at $14.05. In approximately 7 months, Landec has returned 22.39% as of today's recent price of $10.90.
Landec Corporation Sets Third Quarter 2014 Conference Call for March 26, 2014 at 8 a.m. PT; Earnings Release Set for March 25, 2014 After Market
GlobeNewswire - Tue Mar 04, 3:07PM CST
Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday, March 26, 2014 at 8 a.m. Pacific time to discuss its results for the third quarter 2014. Financial results will be reported for the fiscal year 2014 third quarter ended February 23, 2014 after market close on March 25, 2014.
Landec to Present at the 26th Annual ROTH Conference on March 12, 2014
GlobeNewswire - Thu Feb 27, 12:00PM CST
Landec Corporation (Nasdaq:LNDC), a materials science company that develops and markets innovative and patented products for healthy living applications in food and biomedical markets, has been invited to present at the 26th Annual ROTH Conference being held March 10 - 12, 2014 at the Ritz Carlton in Dana Point, California.
Opus Group announces signing of vehicle inspection contract in Colorado
M2 - Wed Feb 26, 5:02AM CST
Opus Group AB (STO:OPUS.ST) announced today that Envirotest Systems Corp (Envirotest) has signed an exclusive contract with the Colorado Department of Public Health and Environment to continue operating the centralised vehicle inspection program for the state of Colorado.
Commercial Applications Expanding for Landec BreatheWay Produce Packaging
GlobeNewswire - Tue Feb 25, 9:25AM CST
Landec Corporation (Nasdaq:LNDC), a materials science company that develops and markets innovative and patented products for healthy living applications in food and biomedical markets, is expanding commercial applications for its patented BreatheWay(R) technology packaging solutions. Landec's BreatheWay technology naturally extends the shelf-life of fresh fruits and vegetables by optimizing the ratio of carbon dioxide and oxygen within the packaging. Expanding commercial applications using BreatheWay technology include:
Landec Shares Down 28.1% Since SmarTrend's Sell Call (LNDC)
Comtex SmarTrend(R) - Wed Feb 19, 4:59PM CST
SmarTrend identified a Downtrend for Landec (NASDAQ:LNDC) on August 12th, 2013 at $14.05. In approximately 6 months, Landec has returned 28.09% as of today's recent price of $10.10.
Global Biomaterials Market 2012-2016: High R&D Costs Could Pose a Challenge to the Growth of the Market
M2 - Wed Feb 05, 10:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/kl58bq/global) has announced the addition of the "Global Biomaterials Market 2012-2016" report to their offering. The analysts forecast the Global Biomaterials market to grow at a CAGR of 14.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Biomaterials market has also been witnessing the emergence of innovative biomaterial products. However, high R&D costs could pose a challenge to the growth of this market. The key vendors dominating this space include Biomet Inc., Evonik Industries AG, Exactech Inc., and Wright Medical Group Inc. The other vendors mentioned in this report are 3DM Inc., AdvanSource Biomaterials Corp., Allergan Inc., Alphatec Spine Inc., Amedica Corp., Angiotech Pharmaceuticals Inc., Basf SE, Bayer AG, Berkeley Advanced Biomaterials Inc., Biocomposites Ltd., BioSyntech Inc., Cam Bioceramics BV, Carpenter Technology Corp., Ceradyne Inc., Ceramtec Collagen Matrix Inc., CollPlant Holdings Ltd., Covalon Technologies Ltd., CryoLife Inc., Dentsply International Inc., Depuy Orthopaedics Inc., Dsm Biomedical Inc., ETEX Corp., Heraeus Medical Components Inc., Hycail Finland OY, Integra LifeSciences Holdings Corp., Invibio Ltd., Kyocera Corp., Landec Corp., Materion Corp., Medtronic Inc., Morgan Technical Ceramics, Orthovita Inc., Osteotech Inc., Purac Biomaterials, RTI Biologics Inc., Sigma-Aldrich Corp., Starch Medical Inc., Stryker Corp., Ticona GmbH, Ulbrich Stainless Steels & Special Metals Inc., and Zimmer Holdings Inc. Commenting on the report, an analyst from the team said: There has been steady innovation in the Global Biomaterials market with several players increasing R&D expenditure every year. For instance, the use of carbon fiber in conjunction with biomaterials for the manufacture of composite materials is being explored. While innovation is imperative in an industry such as this where competition is rampant, the need for novel solutions to cater to patient needs in the Medical industry is also expected to lead to innovation in the market. Biomaterials were traditionally used for repair and replacement of body tissues. However, there has been an increasing focus on the provision of biomaterials for self-healing in patients. Thus, the Global Biomaterials market is expected to witness innovation. For more information visit http://www.researchandmarkets.com/research/kl58bq/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Landec Down 28.2% Since SmarTrend Downtrend Call (LNDC)
Comtex SmarTrend(R) - Wed Feb 05, 9:46AM CST
SmarTrend identified a Downtrend for Landec (NASDAQ:LNDC) on August 12th, 2013 at $14.05. In approximately 6 months, Landec has returned 28.16% as of today's recent price of $10.09.
Landec Shares Down 19.8% Since SmarTrend's Sell Call (LNDC)
Comtex SmarTrend(R) - Tue Jan 21, 5:28PM CST
SmarTrend identified a Downtrend for Landec (NASDAQ:LNDC) on August 12th, 2013 at $14.05. In approximately 5 months, Landec has returned 19.76% as of today's recent price of $11.27.
Landec Down 19.3% Since SmarTrend Downtrend Call (LNDC)
Comtex SmarTrend(R) - Mon Jan 13, 9:34AM CST
SmarTrend identified a Downtrend for Landec (NASDAQ:LNDC) on August 12th, 2013 at $14.05. In approximately 5 months, Landec has returned 19.33% as of today's recent price of $11.33.
Post Earnings Update: Landec Has Sunk 5.1% Lower in Past Week (LNDC)
Comtex SmarTrend(R) - Mon Jan 13, 6:59AM CST
A week ago on January 2nd, 2014 Landec (NASDAQ:LNDC) reported earnings and analysts, on average, expected earnings of $0.13 on sales of $124.0 million. Landec actually reported earnings of $0.13 per share on sales of $120.0 million, matching EPS estimates and missing revenue estimates by $4.0 million. Since the company's report, shares of Landec have fallen from $12.02 to $11.41, representing a loss of 5.1% in the past 11 days.
Landec Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 09, 11:00AM CST
On Jan 8, Zacks Investment Research downgraded materials sciences company Landec Corporation to a Zacks Rank #5 (Strong Sell).
Landec Appoints Molly Hemmeter as COO - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 11:10AM CST
Landec Corporation, a materials sciences company, has announced the appointment of Molly A. Hemmeter as its Chief Operating Officer (COO).
Landec Corporation hires Molly Hemmeter as COO
M2 - Mon Jan 06, 7:54AM CST
Materials science company Landec Corporation (NasdaqGS:LNDC) revealed on Friday the election of Molly A. Hemmeter as its chief operating officer, reporting directly to its CEO and board chair, Gary Steele.
Landec Corporation Announces Appointment of Molly Hemmeter as Chief Operating Officer
GlobeNewswire - Fri Jan 03, 8:15AM CST
Landec Corporation (Nasdaq:LNDC) a developer and marketer of technology-based materials science products for food and medical applications today announced the appointment of Molly A. Hemmeter as Landec's Chief Operating Officer. Ms. Hemmeter joined Landec in June 2009 as VP of Business Development and subsequently became Landec's Chief Commercial Officer. Ms. Hemmeter will report directly to Gary Steele, Landec's CEO and Chairman of the Board.
LANDEC CORP.
at Investor's Business Daily - Thu Jan 02, 5:49PM CST
LANDEC CORP. (LNDC), a materials maker for the food and health care industries, said Q2 EPS fell 61% to 13 cents, in line with views. Revenue rose 5% to $120 mil, under. Shares fell 3.1%.
